| Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models DT Malone, MN Hill, T Rubino British journal of pharmacology 160 (3), 511-522, 2010 | 326 | 2010 |
| Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice LE Long, DT Malone, DA Taylor Neuropsychopharmacology 31 (4), 795-803, 2006 | 224 | 2006 |
| Biased agonism and biased allosteric modulation at the CB1 cannabinoid receptor E Khajehali, DT Malone, M Glass, PM Sexton, A Christopoulos, K Leach Molecular pharmacology 88 (2), 368-379, 2015 | 150 | 2015 |
| Adopting an active learning approach to teaching in a research-intensive higher education context transformed staff teaching attitudes and behaviours PJ White, I Larson, K Styles, E Yuriev, DR Evans, PK Rangachari, ... Higher Education Research & Development 35 (3), 619-633, 2016 | 127 | 2016 |
| Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia A Gururajan, DA Taylor, DT Malone Behavioural brain research 222 (2), 299-308, 2011 | 119 | 2011 |
| Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats DT Malone, D Jongejan, DA Taylor Pharmacology Biochemistry and Behavior 93 (2), 91-96, 2009 | 117 | 2009 |
| Modulation by fluoxetine of striatal dopamine release following Δ9‐tetrahydrocannabinol: a microdialysis study in conscious rats DT Malone, DA Taylor British journal of pharmacology 128 (1), 21-26, 1999 | 109 | 1999 |
| The effect of Δ9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats DT Malone, DA Taylor Behavioural brain research 166 (1), 101-109, 2006 | 93 | 2006 |
| Consequences of early life MK-801 administration: long-term behavioural effects and relevance to schizophrenia research AL Lim, DA Taylor, DT Malone Behavioural brain research 227 (1), 276-286, 2012 | 89 | 2012 |
| Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague–Dawley rats A Gururajan, DA Taylor, DT Malone Journal of psychopharmacology 26 (10), 1317-1332, 2012 | 86 | 2012 |
| Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats DT Malone, CS Kearn, L Chongue, K Mackie, DA Taylor Neuroscience 152 (1), 265-272, 2008 | 80 | 2008 |
| Does cannabidiol have a role in the treatment of schizophrenia? A Gururajan, DT Malone Schizophrenia research 176 (2-3), 281-290, 2016 | 64 | 2016 |
| A two-hit model: behavioural investigation of the effect of combined neonatal MK-801 administration and isolation rearing in the rat AL Lim, DA Taylor, DT Malone Journal of Psychopharmacology 26 (9), 1252-1264, 2012 | 63 | 2012 |
| Current pharmacological models of social withdrawal in rats: relevance to schizophrenia A Gururajan, DA Taylor, DT Malone Behavioural pharmacology 21 (8), 690-709, 2010 | 62 | 2010 |
| Modulation of Δ9‐tetrahydrocannabinol‐induced hypothermia by fluoxetine in the rat DT Malone, DA Taylor British journal of pharmacology 124 (7), 1419-1424, 1998 | 59 | 1998 |
| The effect of social isolation on rat brain expression of genes associated with endocannabinoid signaling SA Robinson, RE Loiacono, A Christopoulos, PM Sexton, DT Malone Brain research 1343, 153-167, 2010 | 56 | 2010 |
| Altered Amygdala Excitation and CB1 Receptor Modulation of Aggressive Behavior in the Neuroligin-3R451C Mouse Model of Autism S Hosie, DT Malone, S Liu, M Glass, PA Adlard, AJ Hannan, ... Frontiers in cellular neuroscience 12, 234, 2018 | 55 | 2018 |
| Male contraception via simultaneous knockout of α1A-adrenoceptors and P2X1-purinoceptors in mice CW White, YT Choong, JL Short, B Exintaris, DT Malone, AM Allen, ... Proceedings of the National Academy of Sciences 110 (51), 20825-20830, 2013 | 46 | 2013 |
| Involvement of somatodendritic 5-HT1A receptors in Δ9-tetrahydrocannabinol-induced hypothermia in the rat DT Malone, DA Taylor Pharmacology Biochemistry and Behavior 69 (3-4), 595-601, 2001 | 43 | 2001 |
| CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice R Khella, JL Short, DT Malone Psychopharmacology 231, 3071-3087, 2014 | 41 | 2014 |
